Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Crohn's Disease or Ulcerative Colitis | MicrobiomeTrials← Back to trialsNCT05003947
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Crohn's Disease or Ulcerative Colitis
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2022-06-11Est. Completion: 2028-10
Enrollment target: 15 participants Locations- Prodromos Stem Cell Institute, Naples, Florida, United States
- Prodromos Stem Cell Institute, Athens, Greece
Other microbiome trials you might be interested in
Uveitis
Background:
\- Uveitis is a general term describing a group of inflammatory diseases of the eye. The causes of uveitis …
Bethesda, United StatesCompleted Jun 29, 2022
Inflammatory Bowel Diseases (IBD)Crohn DiseaseColitis, Ulcerative
Difficult-to-treat inflammatory bowel disease (DTT-IBD) represents a heterogeneous group of patients with treatment-refr…
Multiple LocationsEst. completion Oct 31, 2032
Inflammatory Bowel Disease
This study evaluates oral Lactobacillus reuteri as an adjunct therapy for 2 months. Endoscopic assessments will be perfo…
Suqian, ChinaCompleted Mar 30, 2026